NICOLE HOHMAN: Open Payments
NPI 1710508973 · OSWEGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 16 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $480 · 2025 $838
Food & beverage: $823Education: $15
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $221 |
| ARGENX US, INC. | 2 | $147 |
| Agios Pharmaceuticals, Inc. | 1 | $136 |
| TG Therapeutics, Inc. | 1 | $124 |
| Alexion Pharmaceuticals, Inc. | 2 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Octapharma USA, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: VYEPTI, PYRUKYND, BRIUMVI, VYVGART, ULTOMIRIS, VYVGART HYTRULO, OCTAGAM IMMUNE GLOBULIN (HUMAN), SKYRIZI.
Industry payments across IL — which companies pay providers there.
